Trump’s Hydroxychloroquine Cocktail Connected to 45 Percent Increased Risk of Death

“What do you have to lose?” the president recently asked.

Yuri Gripas/ZUMA

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

“What do you have to lose?” President Donald Trump asked reporters last week while, once again, promoting the controversial drug hydroxychloroquine as a potential coronavirus treatment. 

It turns out, as experts have repeatedly warned, a whole lot.

A new Lancet study released on Friday and first reported by the Washington Post revealed that taking hydroxychloroquine to combat COVID-19 was connected to a significantly increased chance of death. The study, which examined 96,032 patients and is the largest to investigate the antimalarial drug’s potential in fighting the virus, had even more alarming news for taking hydroxychloroquine with an antibiotic, the combination once touted by Trump as a “gamechanger” in the fight against coronavirus. “For those receiving hydroxychloroquine and an antibiotic—the cocktail endorsed by Trump—there was a 45 percent increased risk of death and a 411 percent increased risk of serious heart arrhythmias,” the Post reported. The study doesn’t necessarily extend to those taking hydroxychloroquine as a preventive measure, as Trump claimed this week to be doing.

The astounding findings come on the heels of a study published last month that reported more deaths among US veterans treated with hydroxychloroquine than those who received standard care. Trump initially claimed that he hadn’t seen the veterans’ study—a curious assertion considering his aggressive campaign to promote the drug—but then on Tuesday accused the medical researchers of political motivation. “That was a false study done,” he said at a White House event. “It was given by obviously not friends of the administration.”

The president has not yet offered a conspiratorial angle with which to discredit the Lancet study, but something tells me that’s inevitable.

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you'll agree is worth supporting.

payment methods

ONE MORE QUICK THING:

Or at least we hope. It’s fall fundraising time, and we’re trying to raise $250,000 to help fund Mother Jones’ journalism during a shorter than normal three-week push.

If you’re reading this, a fundraising pitch at the bottom of an article, you must find our team’s reporting valuable and we hope you’ll consider supporting it with a donation of any amount right now if you can.

It’s really that simple. But if you’d like to read a bit more, our membership lead, Brian Hiatt, has a post for you highlighting some of our newsroom's impressive, impactful work of late—including two big investigations in just one day and covering voting rights the way it needs to be done—that we hope you’ll agree is worth supporting.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate